BidaskClub Downgrades Phibro Animal Health (PAHC) to Strong Sell

Phibro Animal Health (NASDAQ:PAHC) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a report issued on Tuesday.

Several other research firms have also issued reports on PAHC. Bank of America reissued an “underperform” rating and set a $33.00 target price on shares of Phibro Animal Health in a research note on Wednesday, August 23rd. Credit Suisse Group increased their target price on Phibro Animal Health from $36.00 to $37.00 and gave the stock an “outperform” rating in a research note on Thursday, August 31st. Piper Jaffray Companies set a $42.00 target price on Phibro Animal Health and gave the stock a “buy” rating in a research note on Friday, August 25th. Zacks Investment Research lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Finally, ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $38.25.

Phibro Animal Health (NASDAQ:PAHC) opened at $33.65 on Tuesday. Phibro Animal Health has a 12 month low of $26.10 and a 12 month high of $40.25. The company has a market capitalization of $1,328.05, a price-to-earnings ratio of 21.60, a PEG ratio of 3.88 and a beta of 1.27. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Monday, November 6th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.01. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The firm had revenue of $193.40 million for the quarter, compared to analyst estimates of $189.89 million. During the same quarter in the prior year, the company earned $0.36 EPS. Phibro Animal Health’s revenue was up 2.9% on a year-over-year basis. sell-side analysts expect that Phibro Animal Health will post 1.57 earnings per share for the current year.

In other Phibro Animal Health news, insider Dean J. Warras sold 10,000 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $35.70, for a total value of $357,000.00. Following the sale, the insider now owns 10,000 shares of the company’s stock, valued at approximately $357,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 51.88% of the stock is owned by company insiders.

Hedge funds have recently bought and sold shares of the business. Municipal Employees Retirement System of Michigan increased its holdings in shares of Phibro Animal Health by 3.6% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after acquiring an additional 150 shares during the last quarter. KBC Group NV purchased a new position in shares of Phibro Animal Health in the 2nd quarter valued at about $166,000. Victory Capital Management Inc. increased its holdings in shares of Phibro Animal Health by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 5,380 shares of the company’s stock valued at $199,000 after acquiring an additional 807 shares during the last quarter. Capital Fund Management S.A. purchased a new position in shares of Phibro Animal Health in the 2nd quarter valued at about $210,000. Finally, Susquehanna International Group LLP purchased a new position in shares of Phibro Animal Health in the 2nd quarter valued at about $219,000. 48.42% of the stock is currently owned by institutional investors.

WARNING: “BidaskClub Downgrades Phibro Animal Health (PAHC) to Strong Sell” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2017/12/14/bidaskclub-downgrades-phibro-animal-health-pahc-to-strong-sell.html.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply